- Home
- THCH vs XCUR Comparison
THCH vs XCUR Comparison
Compare THCH & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THCH
- XCUR
- Stock Information
- Founded
- THCH 2018
- XCUR 2011
- Country
- THCH China
- XCUR United States
- Employees
- THCH N/A
- XCUR N/A
- Industry
- THCH Blank Checks
- XCUR Biotechnology: Pharmaceutical Preparations
- Sector
- THCH Finance
- XCUR Health Care
- Exchange
- THCH Nasdaq
- XCUR Nasdaq
- Market Cap
- THCH 73.0M
- XCUR 74.1M
- IPO Year
- THCH N/A
- XCUR N/A
- Fundamental
- Price
- THCH $2.63
- XCUR $11.06
- Analyst Decision
- THCH
- XCUR
- Analyst Count
- THCH 0
- XCUR 0
- Target Price
- THCH N/A
- XCUR N/A
- AVG Volume (30 Days)
- THCH 9.8K
- XCUR 31.7K
- Earning Date
- THCH 06-04-2025
- XCUR 06-16-2025
- Dividend Yield
- THCH N/A
- XCUR N/A
- EPS Growth
- THCH N/A
- XCUR N/A
- EPS
- THCH N/A
- XCUR N/A
- Revenue
- THCH $190,593,087.00
- XCUR $500,000.00
- Revenue This Year
- THCH N/A
- XCUR N/A
- Revenue Next Year
- THCH N/A
- XCUR N/A
- P/E Ratio
- THCH N/A
- XCUR N/A
- Revenue Growth
- THCH N/A
- XCUR N/A
- 52 Week Low
- THCH $2.15
- XCUR $1.44
- 52 Week High
- THCH $6.00
- XCUR $36.00
- Technical
- Relative Strength Index (RSI)
- THCH 43.75
- XCUR 49.48
- Support Level
- THCH $2.61
- XCUR $9.81
- Resistance Level
- THCH $2.84
- XCUR $11.60
- Average True Range (ATR)
- THCH 0.13
- XCUR 0.91
- MACD
- THCH 0.01
- XCUR 0.06
- Stochastic Oscillator
- THCH 48.94
- XCUR 43.98
About THCH TH International Limited Ordinary shares
TH International Ltd is the parent company of the franchise of Tim Hortons coffee shops and has the rights to operate Tim Hortons coffee shops in mainland China, Hong Kong, and Macau. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. It is also the operator and developer of Popeyes brand in Mainland China. The firm has two reportable segments; Tim Hortons which generates key revenue, and Popeyes. The company's revenue is derived from its operations in the PRC.
About XCUR Exicure Inc.
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.